Review of renal carcinoma with t(6;11)(p21;q12) with focus on clinical and pathobiological aspects.

Recently, a new category of MiTF/TFE family translocation carcinomas of the kidney has been proposed. This category includes Xp11.2 renal cell carcinoma (RCC) and the t(6;11) RCC. These tumors share clinical, morphological, immunohistochemical and molecular genetic features. In this article, we review t(6;11) RCC. This tumor predominantly affects children and young adults. Macroscopically, the tumor generally forms a well circumscribed mass. Satellite nodules may be observed. Histologically, the tumor comprises large cells and small cells surrounded by basement membrane material. Immunohistochemically, tumor cells show nuclear immunolabeling for TFEB and usually express Cathepsin-K in the cytoplasm. Karyotyping detects the rearrangement between chromosome 6p21 and chromosome 11q12. Alpha-TFEB fusion can be detected by reverse transcriptase polymerase chain reaction (RT-PCR) or fluorescence in situ hybridization (FISH). Most cases affecting children and young adults seem to be indolent, but some adult cases have presented with metastasis or caused death. As previously reported cases remain limited to date, further examination in a large scale study will be needed in order to elucidate clinical behavior and molecular characteristics.

[1]  Y. Chen,et al.  [Renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with lymph node metastasis diagnosed after an injury accident: report of a case]. , 2014, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[2]  P. Sathe,et al.  Xp11 translocation renal cell carcinoma. , 2013, Indian journal of pathology & microbiology.

[3]  M. Ladanyi,et al.  Molecular Confirmation of t(6;11)(p21;q12) Renal Cell Carcinoma in Archival Paraffin-embedded Material Using a Break-apart TFEB FISH Assay Expands its Clinicopathologic Spectrum , 2012, The American journal of surgical pathology.

[4]  W. Linehan,et al.  Translocation Renal Cell Carcinomas in Adults: A Single-institution Experience , 2012, The American journal of surgical pathology.

[5]  Ximing J. Yang,et al.  A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases. , 2012, Human pathology.

[6]  C. Pan,et al.  Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. , 2012, Histology and histopathology.

[7]  Y. Ishikawa,et al.  Diverse Fusion Patterns and Heterogeneous Clinicopathologic Features of Renal Cell Carcinoma With t(6;11) Translocation , 2012, The American journal of surgical pathology.

[8]  N. Kuroda,et al.  Renal carcinoma with (6;11)(p21;q12) translocation: Report of an adult case , 2011, Pathology international.

[9]  F. Izquierdo-García,et al.  Renal Translocation Carcinoma With Expression of TFEB , 2011, International journal of surgical pathology.

[10]  Xiong-zeng Zhu,et al.  Renal cell carcinoma with t(6;11) translocation: a patient case with a novel Alpha-TFEB fusion point. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Parwani,et al.  Xp11.2 translocation renal cell carcinoma. , 2010, Archives of pathology & laboratory medicine.

[12]  C. Pan,et al.  Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas , 2009, Modern Pathology.

[13]  Karl J. Dykema,et al.  Renal Translocation Carcinomas: Clinicopathologic, Immunohistochemical, and Gene Expression Profiling Analysis of 31 Cases With a Review of the Literature , 2008, The American journal of surgical pathology.

[14]  L. Vreede,et al.  Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas , 2007, Cytogenetic and Genome Research.

[15]  M. Ladanyi,et al.  Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.

[16]  L. Pecciarini,et al.  Characterization of t(6;11)(p21;q12) in a renal‐cell carcinoma of an adult patient , 2007, Genes, Chromosomes and Cancer.

[17]  M. Ladanyi,et al.  The evolving story of renal translocation carcinomas. , 2006, American journal of clinical pathology.

[18]  M. Ladanyi,et al.  Translocation carcinomas of the kidney after chemotherapy in childhood. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Ladanyi,et al.  Translocation carcinomas of the kidney. , 2005, Clinics in laboratory medicine.

[20]  M. Ladanyi,et al.  Renal Carcinomas With the t(6;11)(p21;q12): Clinicopathologic Features and Demonstration of the Specific Alpha-TFEB Gene Fusion by Immunohistochemistry, RT-PCR, and DNA PCR , 2005, The American journal of surgical pathology.

[21]  M. Mansukhani,et al.  Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. , 2004, Cancer genetics and cytogenetics.

[22]  M. Ladanyi,et al.  Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas. , 2003, Pathology.

[23]  E. van den Berg,et al.  Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. , 2003, Human molecular genetics.

[24]  T. Shuin,et al.  Review of renal oncocytoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.

[25]  M. Ladanyi,et al.  Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Enzan,et al.  Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.

[27]  P. Argani,et al.  A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. , 2001, The American journal of pathology.

[28]  E. Berg,et al.  Two cases of renal cell carcinoma, clear cell type, revealing a t(6;11)(p21;q13) , 1996 .

[29]  P. Argani,et al.  Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney , 2012, Modern Pathology.

[30]  O. Hes,et al.  A distinctive translocation carcinoma of the kidney [“rosette-like forming,” t(6;11), HMB45-positive renal tumor] , 2008, International Urology and Nephrology.

[31]  H. Enzan,et al.  Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.

[32]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .